UMIN ID: C000000047
Registered date:07/08/2005
A phase I/II study of percutaneous radiofrequency ablation for metastatic bone tumor (JIVROSG-0208)
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Symptomatic metastatic bone tumor |
Date of first enrollment | 2004/03/01 |
Target sample size | 33 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Radiofrequency ablation needle is percutaneouly inserted into the metastatic bone tumor and radiofrequency ablation is performed. |
Outcome(s)
Primary Outcome | Adverse events |
---|---|
Secondary Outcome | Imrovement of symptom measured by Visual Analogue Scale at 1 week after the procedure. |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | 1) Cardiac pacemaker. 2) Artery or nerve along the puncture route. 3) Pregnancy. 4) No symptom or VAS of less than 3. |
Related Information
Primary Sponsor | Japan Interventional Radiology in Oncology Study Group (JIVROSG) |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Ministry of Health, Labour and Welfare |
Secondary ID(s) |
Contact
public contact | |
Name | Yasuaki Arai |
Address | 5-1-1,Tsukiji,Chuo-ku,Tokyo,104-0045,Japan Japan |
Telephone | 03-3542-2511 |
jivrosgoffice@ml.res.ncc.go.jp | |
Affiliation | JIVROSG, Coordinating Office Division of Diagnostic Radiology, National Cancer Center Hospital |
scientific contact | |
Name | Noboru Tanigawa |
Address | 10-15, Fumizono-cho, Moriguchi-shi, Osaka 570-8507, Japan Japan |
Telephone | 06-6992-1001 |
Affiliation | Kansai Medical University Department of Radiology |